Journey Medical Corp (DERM) financials · rev $61.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Journey Medical Corp (DERM) rev $61.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $61.9M | $56.1M |
| Cost of Revenue | $20.9M | $20.9M |
| Gross Profit | $40.9M | $35.3M |
| Operating Income | -$8.17M | -$13.7M |
| Net Income | -$11.4M | -$14.7M |
| EPS (Diluted) | -$0.47 | -$0.72 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $94.6M | $80.2M |
| Current Assets | $66.9M | $48.2M |
| Cash & Equivalents | $24.1M | $20.3M |
| Inventory | $9.62M | $14.4M |
| Total Liabilities | $62.7M | $60.2M |
| Current Liabilities | $37.4M | $35.2M |
| Long-term Debt | $25.3M | $24.9M |
| Total Debt | $25.3M† | $24.9M† |
| Shareholders' Equity | $31.9M | $20.1M |
| Retained Earnings | -$98.5M | -$87.0M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.4M | -$9.13M |
| CapEx | N/A | $15.0M |
| Investing Cash Flow | N/A | -$15.0M |
| Financing Cash Flow | $16.2M | $17.0M |
| Net Change in Cash | $3.79M | -$7.13M |
| Free Cash Flow | N/A | -$24.1M |
FAQ
What is DERM P/E and revenue?
Journey Medical Corp (DERM) rev $61.9M.
What is DERM revenue?
Journey Medical Corp last cached revenue is $61.9M (FY2025).
Is DERM profitable?
Journey Medical Corp last cached net income is -$11.4M (FY2025).
What are DERM total assets?
Journey Medical Corp last cached total assets are $94.6M (FY2025).
What is DERM free cash flow?
No cached cash-flow row for DERM yet.
Not investment advice. Cached statements, not a live tape.